Potentiation of fibroblast DNA synthesis by a phenytoin-induced mononuclear cell derived factor in vitro
- PMID: 2704979
- DOI: 10.1111/j.1600-0722.1989.tb01448.x
Potentiation of fibroblast DNA synthesis by a phenytoin-induced mononuclear cell derived factor in vitro
Abstract
Human mononuclear cells purified by Lymphoprep flotation were incubated with phenytoin (PHT) (20 micrograms/ml) or its metabolite p-HPPH (2 micrograms/ml) in the presence of Concanavalin A (10 micrograms/ml) in vitro. The results indicate that phenytoin and its metabolite p-HPPH induce the release of a mononuclear cell factor(s) that activates quiescent human gingival fibroblast to synthesize DNA.
Similar articles
-
The effect of the phenytoin metabolite p-HPPH on proliferation of gingival fibroblasts in vitro.Acta Odontol Scand. 1982;40(5):353-7. doi: 10.3109/00016358209024080. Acta Odontol Scand. 1982. PMID: 6960635
-
The phenytoin metabolite p-HPPH upregulates prostaglandin biosynthesis in human gingival fibroblasts challenged to interleukin-1.Life Sci. 1993;53(6):503-15. doi: 10.1016/0024-3205(93)90702-5. Life Sci. 1993. PMID: 8341137
-
Phenytoin potentiates accessory cell dependent DNA-synthesis in human lymphocytes in vitro.Scand J Dent Res. 1986 Jun;94(3):202-7. doi: 10.1111/j.1600-0722.1986.tb01754.x. Scand J Dent Res. 1986. PMID: 3488581
-
Regulation of epidermal growth factor receptor metabolism in gingival fibroblasts by phenytoin in vitro.J Oral Pathol Med. 1990 Apr;19(4):188-91. doi: 10.1111/j.1600-0714.1990.tb00822.x. J Oral Pathol Med. 1990. PMID: 2366206
-
Phenytoin and 5-(p-hydroxyphenyl)-5-phenylhydantoin do not alter the effects of bacterial and amplified plaque extracts on cultures of fibroblasts from normal and overgrown gingivae.J Dent Res. 1987 Aug;66(8):1393-8. doi: 10.1177/00220345870660082201. J Dent Res. 1987. PMID: 3476609
Cited by
-
Effect of 5-(p-hydroxyphenyl)-5-phenylhydantoin (p-HPPH) enantiomers, major metabolites of phenytoin, on the occurrence of chronic-gingival hyperplasia: in vivo and in vitro study.Eur J Clin Pharmacol. 1995;49(1-2):51-6. doi: 10.1007/BF00192358. Eur J Clin Pharmacol. 1995. PMID: 8751021